help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 1, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2594
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/6/2416    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soardi, F. C.
Right arrow Articles by de Mello, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soardi, F. C.
Right arrow Articles by de Mello, M. P.
Related Collections
Right arrow Adrenal and Hypertension

Submitted on November 25, 2007
Accepted on March 26, 2008

Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients

F. C. Soardi, M. Barbaro, I. F. Lau, S. H.V. Lemos-Marini, M. T.M. Baptista, G. Guerra-Junior, A. Wedell, S. Lajic, and M. P. de Mello*

Laboratório de Genética Molecular Humana, Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, SP, Brasil; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Departamento de Pediatria/Centro de Investigação em Pediatria, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brasil; Departamento de Clinica Medica, Disciplina de Endocrinologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brasil

* To whom correspondence should be addressed. E-mail: mmello{at}unicamp.br.

Background: Most patients with 21-hydroxylase deficiency carry CYP21A1P-derived mutations, but an increasing number of novel and rare mutations have been reported in disease-causing alleles.

Objective: Functional effects of three novel (p.G56R, p.L107R, p.L142P) and one recurrent (p.R408C) CYP21A2 mutations were investigated. The degree of enzyme impairment caused by p.H62L alone or combined to p.P453S was also analyzed.

Design: The study included ten Brazilian and two Scandinavian patients. To determine the deleterious role of each mutant protein, in vitro assays were performed in transiently transfected COS-1 cells. For a correct genotype-phenotype correlation, the enzymatic activities were evaluated toward the two natural substrates, 17-hydroxyprogesterone and progesterone.

Results: Low levels of residual activities obtained for p.G56R, p.L107R, p.L142P and p.R408C mutants classified them as classical CAH (congenital adrenal hyperplasia) mutations, while the p.H62L showed an activity within the range of non-classical mutations. Apparent kinetic constants for p.H62L confirmed the non-classic classification as the substrate binding capacity (Km) was within the same magnitude for mutant and normal enzymes. A synergistic effect was observed for the allele bearing the p.H62L+p.P453S combination as it caused a significant reduction in the enzymatic activity.

Conclusions: We describe the functional analysis of five rare missense mutations identified in Brazilian and Scandinavian patients. The p.G56R, p.L107R, p.L142P are reported for the first time. Most probably these novel mutations are closer to null than the p.I172N, but for the p.G56R that might not be the case, and the p.H62L is definitely a NC mutation.


Key words: CYP21A2 • enzymatic activity • 21-hydroxylase deficiency







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society